This is a timely book. Ten years ago, molecular biology was purely a research tool holding out the faint hope of improving our understanding of malignancy. Now it is part of the day to day management of patients with cancer and promises to have an increasing role in the future. Characteristic chromosome translocations can be useful in diagnosis e.g.; t(ll;22) It consists of 16 chapters and is divided into two sections, the first introducing recent perspectives in molecular genetics and the second focusing on the application of these principles to specific pathologies. The distinction is not, however, rigid and some of the best chapters interweave both elements. The susceptibility to cancer is discussed in an early chapter which gives a brief overview of the syndromes associated with increased risks of malignancy. Chapters on chromosomal abnormalities and fragile sites follows. Oncogenes, tumour suppressors and their role in the cell cycle are all dealt with in some depth and there are particularly good chapters on oncoproteins and gene amplification. All standard stuff, but where else would one read about transgenic mice, flow cytometry and murine modelling of neuroblastoma? In the section on specific pathologies the authors have, quite rightly, concentrated on those paediatric malignancies where molecular genetics have made an impact rather than listing unsubstantiated findings of dubious significance for a wide range of childhood tumours. This does, however, limit the number of different malignancies that can be discussed and results in a fair degree of repetition (there are five chapters on different aspects of neuroblastoma for example). There are excellent chapters on retinoblastoma, rhabdomyosarcoma, the Wilms' tumour candidate gene and brain tumours.
However, what the book has in breadth it sometimes lacks in consistency. The standard of knowledge expected of the reader varies significantly from chapter to chapter with some presenting hugely detailed molecular findings rendering them indigestible for the non-specialist. Similarly, although most of the technique based chapters concentrate on concepts, some give excess detail including step by step experimental methodology. The truly international authorship ensures a stimulating diversity of approach but does make the style of writing very variable and sometimes difficult to follow.
These criticisms aside I enjoyed the book and felt it fulfilled the role it set itself. The book is dedicated to Dr Raffaele Sansone, one of the three editors, who died tragically before it was published. I think he would have been proud of the finished result. The locoregional treatment of early invasive breast cancer including breast conserving surgery is covered exhaustively and the extensive literature is critically reviewed in a detailed painstaking way. Witness the confusing data on the relevance of locoregional treatment to survival. Often no clear answers are provided, but this will be familiar to those working in this controversial field of oncology. This does not in any way detract from the excellence of the book as this approach is far preferable to the repetition of potentially misleading dogma. The role of mammography in evaluating patients before treatment is dealt with in a lucid and authoritative fashion, well-illustrated by good quality photographs, a feature also of the chapter on the evaluation of patients treated by breast-conserving treatment and radiotherapy. Prognostic factors, both pathological and new markers, and adjuvant systemic therapy receive good up-to-date accounts. British readers will generally find the recommendations for treatment to be in tune with practice here, meta-analyses having done much in recent years to achieve a trans-Atlantic convergence of views. Good chapters deal with reconstructive surgery, in situ disease, locally advanced breast cancer, metastatic disease and its complications, and psychological aspects. There are useful sections on special circumstances such as Paget's disease, breast cancer in pregnancy and in men and bilateral disease. Breast cancer is a major source of malpractice claims in the USA where it has become the most expensive disease for professional insurers and so the editors have given the last word to three lawyers in a chapter on medico-legal aspects. On searching the book for significant omissions, none were found.
There is really very little with which to take exception and to highlight any such minor points here would give them inappropriate prominence in what is intended to be an extremely favourable review. A particular merit of the book is its value as a reference work to facilitate access to the vast literature on the treatment of breast cancer. In this context, the quality of tables summarising salient points in key references is excellent. This admirable text is highly recommended to all involved in treating breast cancer. This book is edited by Nicholas Lemoine and Agememnon Epenetos and is a collection of papers presented at a meeting in London in September 1991. The book is divided into three parts. I: Growth factors and their receptors as targets for therapy, II: Intracellular oncogene products as targets for therapy, and III: Tumour-suppressor genes and immortalis-
